When: Price reaches $132.80-$134.05 (50 SMA reclaim zone)

Then: Execute second tranche if reached; complete trim before Q3 earnings mid-October

When: Price breaks below $136 (50 SMA with buffer) on residual position

Then: Exit residual position

When: Q3 print delivers $5.5B+ net income with stable credit and forward EPS ≥$13.00

Then: Add back trimmed exposure

When: Q3 print $3-4B net income with NIM guidance cut or NCO above 3.5%

Then: Further trim on mixed print

TRIM position to 70-80% of benchmark weight ahead of Q3 earnings catalyst; re-engage after confirmation

• Deteriorating trend across all key technical timeframes: 50 SMA rolled over from 136.70 to 134.05; 10 EMA rolled over from 136.91 to 132.80; lower high at 134.28 on September 25 versus 138.82 on September 11
• Forward P/E of 10.13x and PEG of 0.61 are contingent on 39% earnings expansion that gets revised lower if credit costs surprise upside or capital markets revenue disappoints
• Total assets expanded 10.4% year-over-year; net loans expanded 9.6% year-over-year; rapidly expanding balance sheet at the wrong point in credit cycle with 30-year yield at highest since 2002
• Free cash flow negative in 3 of last 5 quarters; cumulative shareholder returns funded by debt issuance, not sustainable operating earnings
• 30-year yield at highest since 2002 and mortgage rates at 7.58% (three-year high) signal late-cycle credit risk that turns NII tailwinds into credit cost headwinds with a lag
• AI IPO optionality is speculative; does not show up in consensus revenue estimates
• 200 SMA at 124.76 is approximately 4.6% below current price, but if it fails, next reference point is 129.67 from August 20 (already broken intraday); true floor likely 110-115 zone representing 10-15% drawdown
• Stop loss at 127.50 (~$3.30 below current price, ~1x ATR) is vulnerable to being hunted or gapped through on earnings disappointment
• Bull case scenario: trim means underperforming by 1.5-4% if stock rallies 5-8%; recoverable outcome that allows re-engagement after confirmation
• Bear case scenario: credit cost spike, NIM guidance softening, or ACL build could produce 10-15% single-session drop and $13-20 per share drawdown

→ vs aggressive: Structural uptrend argument ignores that 50 SMA has rolled over from 136.70 to 134.05, 10 EMA from 136.91 to 132.80, and stock made lower high at 134.28 vs 138.82—the only support left is a 200 SMA never tested under this regime with 30-year yields at highest since 2002

→ vs aggressive: Low valuation multiples are contingent on 39% earnings expansion that the market is skeptical of; a stock trading at low forward P/E in front of a binary catalyst with deteriorating technicals is a value trap, not a gift

→ vs aggressive: Framing debt-funded buybacks as benign 'liability management' misses that a 10.4% asset expansion and 9.6% loan growth at this point in the credit cycle creates unmodeled charge-off and ACL build risk

→ vs aggressive: Using operating cash flow technicalities (loan originations as outflows) to dismiss underlying data obscures that 3 of last 5 quarters had negative free cash flow funded by debt issuance

→ vs aggressive: Cherry-picking NII tailwinds while ignoring that 30-year yield at highest since 2002 and mortgage rates at 7.58% signal late-cycle credit risk that builds credit cost headwinds with a lag

→ vs aggressive: AI IPO optionality from consortium deals that may not happen, may not price in Q4, and may not include Citigroup as meaningful underwriter cannot support position-sizing; it's hope, not investing

→ vs aggressive: Risk-reward asymmetry is misstated: if 200 SMA fails, next floor is 110-115 zone, not 125, representing $13-16 per share (not 4-5% downside) against the aggressive analyst's $3.30 tight stop that gets hunted or gapped through

→ vs aggressive: 'Half-pregnant' criticism of trimming conflates conviction with action; trimming 30-50% ahead of binary catalyst is textbook prudent institutional risk management, not capitulation

25-35% trim in tranches with defined re-engagement framework; neither full sell nor full hold

• 86% odds of another Fed hike and 30-year yields at multi-decade highs support bank NII expansion
• 10x forward earnings multiple with 0.61 PEG and 12.8% NII growth represents attractive valuation, not a value trap
• Technical deterioration (below 10 EMA, below 50 SMA, on Bollinger lower band, weakening MACD/RSI) and binary earnings catalyst in 3 weeks warrant reduced exposure
• Trader's 30-50% trim is directionally sound but overdone; 25-35% trim is sufficient to reduce risk while maintaining meaningful participation
• Base case is 3-7% move in either direction around print, not the 10-15% worst-case scenario
• Execute trim in tranches: half at $131.50-$132.80, half at $132.80-$134.05; if neither reached, trim on small bounce into print
• Must have explicit re-engagement plan: add back if stock holds $130+ with improving momentum post-print; reduce further if closes below $124.76

→ vs aggressive: Category error conflating long-term fundamentals (PEG 0.61) with short-term position sizing into binary catalyst; stop placement 1x ATR below price risks gap-through on earnings miss

→ vs aggressive: AI IPO optionality argument is speculative consortium revenue not yet announced or priced

→ vs conservative: 'Sell into resistance' framing assumes price action that may not materialize; stock could chop sideways and report from current levels

→ vs conservative: 'Value trap' framing is intellectually lazy; value trap requires earnings collapse, not accelerating earnings with mechanical buyback reducing share count

→ vs conservative: '10-15% drawdown potential' is worst-case fear-mongering treating extreme scenario as base case rather than multi-step sequence requiring macro deterioration AND earnings miss AND technical breakdown